Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Jeschke

Showing results (381-390 of 401) with videos related to

Pageof 41
Sort By:
Journal of Reproductive Immunology|March 4, 2021
Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsiaSarah Meister, Laura Hahn, Susanne Beyer, et al.
International Journal of Molecular Sciences|February 15, 2022
Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Cells|September 28, 2021
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by RupatadineEileen Deuster, Ivi Hysenaj, Maja Kahaly, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2017
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancerAurelia Vattai, Elif Akyol, Christina Kuhn, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 2, 2021
The decidual expression of Interleukin-7 is upregulated in early pregnancy lossTheresa Vilsmaier, Niklas Amann, Sanja Löb, et al.
Cancers|July 29, 2023
Elderly and Patients with Large Breast Volume Have an Increased Risk of Seroma Formation after Mastectomy-Results of the SerMa Pilot StudyMelitta Beatrice Köpke, Carl Mathis Wild, Mariella Schneider, et al.
Biomedicines|July 2, 2021
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling PathwayYue Liao, Susann Badmann, Till Kaltofen, et al.
Journal of Reproductive Immunology|March 16, 2024
Placental expression of inflammatory Galectin-12 is associated with gestational diabetesChristina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancerJuliane Reichenbach, Patricia Fraungruber, Doris Mayr, et al.
Frontiers in Oncology|October 11, 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian CancerNicole Elisabeth Topalov, Doris Mayr, Clemens Scherer, et al.
Pageof 41

Showing results (381-390 of 401) with videos related to

Sort By:
Pageof 41
Journal of Reproductive Immunology|March 4, 2021
Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsiaSarah Meister, Laura Hahn, Susanne Beyer, et al.
International Journal of Molecular Sciences|February 15, 2022
Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2Sarah Meister, Laura Hahn, Susanne Beyer, et al.
Cells|September 28, 2021
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by RupatadineEileen Deuster, Ivi Hysenaj, Maja Kahaly, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2017
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancerAurelia Vattai, Elif Akyol, Christina Kuhn, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 2, 2021
The decidual expression of Interleukin-7 is upregulated in early pregnancy lossTheresa Vilsmaier, Niklas Amann, Sanja Löb, et al.
Cancers|July 29, 2023
Elderly and Patients with Large Breast Volume Have an Increased Risk of Seroma Formation after Mastectomy-Results of the SerMa Pilot StudyMelitta Beatrice Köpke, Carl Mathis Wild, Mariella Schneider, et al.
Biomedicines|July 2, 2021
Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling PathwayYue Liao, Susann Badmann, Till Kaltofen, et al.
Journal of Reproductive Immunology|March 16, 2024
Placental expression of inflammatory Galectin-12 is associated with gestational diabetesChristina Buschmann, Laura Unverdorben, Julia Knabl, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancerJuliane Reichenbach, Patricia Fraungruber, Doris Mayr, et al.
Frontiers in Oncology|October 11, 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian CancerNicole Elisabeth Topalov, Doris Mayr, Clemens Scherer, et al.
Pageof 41